Previous Close | 7.77 |
Open | 7.74 |
Bid | 7.78 x 800 |
Ask | 7.79 x 1100 |
Day's Range | 7.61 - 7.83 |
52 Week Range | 2.43 - 8.60 |
Volume | |
Avg. Volume | 622,104 |
Market Cap | 910.068M |
Beta (5Y Monthly) | 1.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings Date | Feb 26, 2024 - Mar 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.65 |
Subscribe to Yahoo Finance Plus to view Fair Value for MDXG
MARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum Capital Group 14th Annual Alpha Select Conference Thursday, November 16, 2023Sheraton New York Times Square Hotel811 7th Avenue, W 53rd St New York, NY Mizuho Medical Device & Healthcare Services Summit 2023Wednesday, December 6, 2023Sofitel New York45 W 44th StNew
Company Will Sponsor Lunch Symposium on November 3, 2023MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in Las Vegas, NV. In addition, the Company will participate in the conference’s exhibition at booth number 511. In the session, Drs. Mouawad, Tettelbach, and Wahab will review r
MiMedx Group, Inc. ( NASDAQ:MDXG ) is possibly approaching a major achievement in its business, so we would like to...